{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-25-000159","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2025-11-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.019205+00:00","generated_at":"2026-05-16T22:25:25.536148+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Surgery Partners Q3 revenue up 6.6% to $821.5M, net loss $22.7M; FY guidance cut","bullets":["Revenue $821.5M (+6.6% YoY); same-facility revenue +6.3%, cases +3.4%.","Net loss attributable to SGRY of $22.7M; Adjusted EBITDA $136.4M (+6.1% YoY).","Full-year 2025 guidance: revenue $3.275-3.30B, Adjusted EBITDA $535-540M (revised down).","Leverage ratio 4.2x net debt/EBITDA; Q3 operating cash flow $83.6M vs $65.2M YoY.","Management cites softer volume, payor mix, and delayed capital deployment for guidance revision."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-25-000159","json":"https://secwatch.observer/filing/0001638833-25-000159.json","markdown":"https://secwatch.observer/filing/0001638833-25-000159.md","text":"https://secwatch.observer/filing/0001638833-25-000159.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883325000159/0001638833-25-000159-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883325000159/sgry-20251110.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T22:25:25.536148+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}